Investigating the tumor - Immune cell crosstalk in ex vivo glioblastoma models

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	ii79–ii80
Journal	Neuro-Oncology
Volume	24
Issue number	Suppl.2
DOIs	https://doi.org/10.1093/neuonc/noac174.278
Publication status	Published - 5 Sept 2022
Event	17th Meeting of the European Association of Neuro-Oncology - Vienna, Austria Duration: 15 Sept 2022 → 18 Sept 2022

Access to Document

@article{55d4aac0be574a1ea826779945230c56,

title = "Investigating the tumor - Immune cell crosstalk in ex vivo glioblastoma models",

author = "Rezaeipour M and E. Klein and C. Dording and Niclou, \{S. P.\} and A. Golebiewska",

year = "2022",

month = sep,

day = "5",

doi = "10.1093/neuonc/noac174.278",

language = "English",

volume = "24",

pages = "ii79–ii80",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "Suppl.2",

note = "17th Meeting of the European Association of Neuro-Oncology ; Conference date: 15-09-2022 Through 18-09-2022",

}

TY - JOUR

T1 - Investigating the tumor - Immune cell crosstalk in ex vivo glioblastoma models

AU - M, Rezaeipour

AU - Klein, E.

AU - Dording, C.

AU - Niclou, S. P.

AU - Golebiewska, A.

PY - 2022/9/5

Y1 - 2022/9/5

U2 - 10.1093/neuonc/noac174.278

DO - 10.1093/neuonc/noac174.278

M3 - Meeting Abstract

SN - 1522-8517

VL - 24

SP - ii79–ii80

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - Suppl.2

T2 - 17th Meeting of the European Association of Neuro-Oncology

Y2 - 15 September 2022 through 18 September 2022

ER -